Release 8.8
Release date: January 21, 2022
Connect Enhancements
- Updated the NantHealth Privacy Policy on Connect, Advisor, and KB Web (#116194).
- Updated the NantHealth Terms of Use on Connect, Advisor, and KB Web (#115588).
- Updated the Appeals status to be clearer to users:
- On the MO Review Screen, updated the Review Decision label to include Appeals (#114919).
- Updated the Appeals Review Decision options to display Decision Overturned or Decision Upheld (#114919).
- Updated the MO, Patient Management, and Payer Dashboards to display the modified statuses for Appeals (#115082):
- Appeal – Upheld Eviti Code Not Issued
- Appeal – Overturned Eviti Code
- Updated the Treatment Plan Summary to display the modified Appeals status (#115130).
Internal Enhancements
- Established a single sign-on (SSO) from a payer portal to Connect’s Payer Dashboard for integration testing in a pre-production environment (#113170, #114927, #115363, #115365 & #115605).
KB Web Enhancements
- Biosimilars Solution Phase 1:
- Completed backend work to support the Generic Drug Family Group concept (#114927).
- Generic Drug Family Management (#115155).
- Medical Policy: Added editing functionality to the URL section (#115121).
- Added more biomarker groups (#116558).
- Reverted format of recently updated KB reports (#115145):
- Medical Policy QA
- Medical Policy Maintenance
- Pathway Policy UAT
- Resolved: Supportive care templates and filters do not load on creating a Supportive Drug Exclude Rule (#114862).
Resolved Issues
- Drug Jx Prompts (Chemotherapy) display requires modification for EZ Path regimens.
- Oncology Provider\Provider Admin\Clinical admin Registration: Hide Autoimmune provider type in oncology end user registration (#114357).
- Request to restrict User Friendly Label input to 40 characters ((#115713).
- Server Error when updating Account Email Address via Payer Users tab (115604).
- Delegated Entity: Ensure XML metadata uses correct recipient info (#116215).
- Technical debt: Fix Compiler Warnings (#108868).